Диссертация (1145006), страница 46
Текст из файла (страница 46)
Magid [et al.] //Am. Heart. J.- 2004.- Vol. 147, №4. - P. 623-629.284. Rihal, C. S. Incidence and prognostic importance of acute renal failure afterpercutaneous coronary intervention /C.S. Rihal, S.C. Textor, D.E. Grill//Circulation. - 2002. - Vol. 105. - P. 2259 – 2264.285. Risk factors for chronic kidney disease in a community-based population: a10-year follow-up study /K. Yamagata, K. Ishida, T.
Sairenchi [et al.] //Kidney Int. –2007, Jan. – Vol. 71, №. 2. – P. 159–166.286. Ronco, C. Cardiorenal syndromes in critical care /C. Ronco, R. Bellomo, P.A.McCulloug //Contrib. Nephrol. – 2010. - Vol. 165. – 366р.287. Ross, R. Atherosclerosis - an inflammatory disease /R. Ross //N. Engl. J. Med. 1999. - Vol. 340. - P. 115–126.288. Sabatine, M.S. Addition of clopidogrel to aspirin and fibrinolytic therapy formyocardial infarction with ST-segment elevation, for the CLARITY-TIMI 28Investigators /M.S. Sabatine //Am. J. Cardiol.- 2003. -Vol. 92.- P.
368-372.282289. Schiffl, H. Update on biomarkers of acute kidney injury: moving closer to clinicalimpact? /H. Schiffl, S.M. Lang //Mol. Diagn. Ther. - 2012 Aug 1. - Vol. 16, № 4. P. 199-207.290. Screening for early chonic kidney disease – what method fits best? /P.E. Jong, T.Hatbesma, R.
T. Gansevoot [et al.] //Nephrol. Dial. Transplant. - 2006. - Vol. 21. P. 2358-2361.291. Schmidt, Н. cGMP: Generators, Effectors and Therapeutic Implications /H.Schmidt, H. Harald, A. Hofmann B. [et al.] //Series: Handbook of ExperimentalPharmacology. - 2009. - Vol. 191. - P.
341-367.292. Serum creatinine as stratified in the RIFLE score for acute kidney injury isassociated with mortality and length of stay for children in the pediatric intensivecare unit /J. Schneider, R. Khemani, Grushkin C. [et al.] //Crit. Care Med. – 2010. –Vol. 38, № 3. – P. 933–939.293. Sheppard, D. Endothelial integrins and angiogenesis: not so simple anymore /D.Sheppard //J. Clin.
Invest. – 2002. – Vol. 110. – P. 913-914.294. Shroff, G.R. Acute myocardial infarction in patients with chronic kidney disease:how are the most vulnerable patients doing ? /G.R. Shroff, C.A. Herzog //Kidney Int.- 2013, Aug. - Vol. 84, № 2.- P. 230 - 233.295. Sima, A.V. Vascular endothelium in atherosclerosis /A.V. Sima, C.S. Stancu, M.Simionescu //Cell. Tissue Res.
- 2009. - Vol. 335, №1. - P.191-203.296. Systematic review, meta-analysis and economic modelling of diagnosticstrategies for suspected acute coronary syndrome /S. Goodacre, P. Thokala, C.Carroll [et al.] //Health Technol. Assess. - 2013. - Vol. 17, № 1. - P. 1– 188.297. SRCL/CL-P1 recognises GalNAc and a carcinoma-associated antigen, Tn antigen/T. Yoshida, Y.
Tsuruta, M. Iwasaki [et al.] //J. Biochem. – 2003. – Vol. 133. - № 3.– P. 271-277.298. Strukova, S. Blood coagulation-dependent inflammation and inflammationdependent thrombosis /S. Strukova //Frontiers in Bioscience. – 2006. – Vol. 11. – P.59-80.283299. Thambyraiah, J. Homocysteine and atherothrombosis – mechanisms of injury /J.Thambyraiah, J.N.Townend //European Heart J.
– 2000. – Vol. 21. – P. 967-974.300. The association between NT-proBNP levers, functional capacity and stage inpatients with heart failure /A. Karabulut, A. Kaplan, C. Aslan [et al.] //Acta Cardiol.- 2005. - Vol.60. - P. 631-638.301. The balance between pro- and anti-inflammatory cytokines is associated withplatelet aggregability in acute coronary syndrome patients /A.M. Gori, F.
Cesari,R.G.F. Marcucci [et al.] //Atherosclerosis. - 2009. - Vol. 202, № 1. - P.255–262.302. The CRUSADE Bleeding Score to Assess Baseline Risk of MajorBleedinginNon-ST-SegmentElevationMyocardialInfarction/S.Subherwal, R.G. Bach, A.Y.Chen [et al.] //J. Amer. Coll. Cardiol.- 2008. Vol. 51, Suppl A: abstr. - P.806-809.303. The cut-off point of interleukin-6 level in acute coronary syndrome /I. Alwi, T.Santoso, S. Suyono [et al.] //Acta Med. Indones.- 2007. - Vol.
39, № 4.- P.174–178.304. The Cytoplasmic Domain ofTissue Factor Contributes to LeucocytesRecruitment and Death in Endotoxemia /L. Sharma, E. Melis, M.J. Hickey [et al.]//Am. J. Pathol. – 2004. – Vol. 165, № 1. – P. 331-340.305. The definition, classification, and prognosis of chronic kidney disease: a KDIGOControversies Conference report /A.S. Levey, P.E. De Jong, J. Coresh [et al.]//Kidney Int.
- 2011 Jul. – Vol. 80, № 1. – P.17–28.306. The diagnostic accuracy of plasma BNP and N-pro BNP in patients referredfrom primary care with suspected heart failure: results of the UK natriuretic peptidein study /A. Zaphiriou, S. Robb, T. Murray-Thomas T. [et al.] //Eur. J. Heart Fail. 2005. - Vol.7. - P.
537-541.307. The prognostic importance of different definitions of worsening renal function incongestive heart failure /S.S. Gottlieb, W. Abraham, J. Butler [et al.] //J. Card. Fail. 2002. – Vol. 8. – P.136–141.308. The prognostic significance of early and late anaemia in acute coronary syndrome/D.S. Ang, M.P. Kao, A. Noman [et al.] //Q.J.M. – 2012. – Vol.105, № 5. – P. 445454.284309.
The second Euro Heart Survey on acute coronary syndromes: characteristics,treatment, and outcome of patients with ACS in Europe and the MediterraneanBasin in 2004 /L. Mandelzweig, A. Battler, V. Boyko [et al.] //Eur. Heart. J. - 2006.– Vol. 27. - P. 2285—2293.310. The severe cardiorenal syndrome: ‘Guyton revisited’/L.G. Bongartz, M.G.Cramer, P.A. Doevendans [et al.] //Eur.
Heart J. - 2005. - Vol. 26, № 1. - P.11–17.311. The task Force on Myocardial Revascularization of the European Society ofCardiology (ESC) and the European Association forCardio-Thoracic Surgery(EASTS). Guidelines on myocardial Revascularizatio /S. Windecker, P.Kolh, F.Alfonso [et.al.] //Eur. Heart J. 2010 [Электpoнный pеcуpc].
- 2014 http://www.athero.ru /ESC_revasc_guide-tabl.pdf (Дaтa oбpaщения: 20.03.2015).312. The TIMI risk score for unstable angina/non-ST elevation MI: a method forprognostication and therapeutic decision making /E.M. Antman, M. Cohen, P.J.Bernink [et al.] //JAMA. – 2000. – Vol. 284, № 7. – P. 835–842.313. The use of subcutaneouserythropoietin and intravenous iron for the treatment ofthe anemia of severe, resistant congestive heart failure improves cardiac and renalfunction and functional cardiac class, and markedly reduces hospitalizations /D.S.Silverberg, D. Wexler, M. Blum [et al.] //J. Am. Coll. Cardiol.
- 2000. - Vol. 35. - P.1737–1744.314. Thrombin generation, inhibition and clinical outcomes in patients with acutemyocardial infarction treated with thrombolytic therapy and heparin: results from theGUSTO-I Trial. GUSTO-I hemostasis substudy group. Global utilization ofstreptokinase and TPA for occluded coronary arteries /C.В. Granger, R.
Becker, R.P.Tracy [et al.] //J. Am. Coll. Cardiol. - 1998. –Vol. 31. - P. 497- 505.315. TIMI Study Group. Association of glomerular filtration rate on presentation withsubsequent mortality in non-ST-segment elevation acute coronary syndrome;observations in 13,307 patients in five TIMI trials /C.M. Gibson, R.L. Dumaine,E.V.
Gelfand [et al.] //Eur. Heart J. - 2004. - Vol. 25, № 22. - P. 1998–2005.285316. Transfer for primary angioplasty versus immediate thrombolysis in acutemyocardial infarction: a meta-analysis /M. Dalby, A. Bouzamondo, P. Lechat [et al.]//Circulation. - 2003. - Vol. 108. - P. 1809-1814.317. Troponin as a risk factor for mortality in critically ill patients without acutecoronary syndromes //P. Ammann, M. Maggiorini, O. Bertel [et al.] //J.
Am. Coll.Cardiol. - 2003. - Vol. 41. - P. 2004–2009.318. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing heart/G. Torre-Amione, S. Karadia, J. Lee. [et al.] //Circulation. - 1996. - Vol. 93. - P.704319. Twenty-two-year trends in incidence of myocardial infarction, coronary heartdisease mortality, and case fatality in 4 US communities, 1987-2008 /W.D.Rosamond, L.E. Chambless, G. Heiss [et al.] /Circulation.
– 2012. – Vol. 125, Iss.15. – P. 1848–1857.320. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery afterkidney transplantation /M.E. Hollmen, L.E. Kyllonen, K.A. Inkinen [et al.] //KidneyInt. — 2011. — Vol. 79. — P. 89-98.321. Usefulness of changes in fasting glucose during hospitalization to predict longterm mortality in patients with acute myocardial infarction /D. Aronson, H.Hammerman, M.
Suleiman [et al.] //Am. J. Cardiol. - 2009. - Vol.104. - P.1013–1017.322. Utilization of early invasive management strategies for high-risk patients withnon-ST-segment elevation acute coronary syndromes. Results from the CRUSADEQuality Improvement Initiative /D.L. Bhatt, M.T. Roe, E.D. Peterson[et al.]∕∕JAMA. - 2004. - Vol. 292.
- P. 2096-2104.323. Vanhoutte, PM. Endothelial dysfunction: the first step toward coronaryarteriosclerosis /P.M. Vanhoutte //Circ. J. - 2009. - Vol. 73, № 4. - P. 595-601.324. Vassalotti, J.A. Testing for chronic kidney disease: a position statement from theNational Kidney Foundation /J.A. Vassalotti, L.A. Stevens, A.S. Levey //Am.
J.Kidney Dis. - 2007.- Vol. 50, № 2. - P. 169–180.286325. Verma, S. Release of cytokins by brain endothelial cells: A polarized response tolipopolysaccharide /S. Verma, R. Nakaoke, S. Dohgu [et al.] //Brain Behav. Immun.– 2006. – Vol. 20, № 5. – P. 449-455.326. Videbaek, J. Serial determination of plasma catecholamines in myocardialinfarction /J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
